SCHEMBL7076158

SCHEMBL7076158

CN(Cc1cc2ccccc2o1)S(=O)(=O)c1ccccc1CC(=O)NO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 6/20 0.44
MMP9 P14780 5/20 0.44
MMP14 P50281 5/20 0.44
MMP1 P03956 4/20 0.44
MMP3 P08254 4/20 0.44
MMP8 P22894 4/20 0.44
MMP12 P39900 4/20 0.44
MMP13 P45452 4/20 0.44
MMP16 P51512 4/20 0.44
ADAM17 P78536 2/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 2/20 0.40
LMNA P02545 2/20 0.40
CLK1 P49759 1/20 0.40
HPGD P15428 1/20 0.40
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7074387 0.88 ALDH1A1 (0.44) MMP2MMP9MMP14MMP1MMP3
SCHEMBL7076161 0.76 ALDH1A1 (0.41) MEN1KMT2ARAB9AALDH1A1NPC1
SCHEMBL7072305 0.74 HDAC3 (0.42) MMP13MEN1KMT2ARAB9AALDH1A1
SCHEMBL7076517 0.70 ALDH1A1 (0.44) MEN1KMT2ARAB9AALDH1A1NPC1
SCHEMBL7077693 0.70 RAB9A (0.49) MEN1KMT2ARAB9AALDH1A1NPC1
SCHEMBL2396386 0.68 LOXL2 (0.46) MEN1KMT2AALDH1A1LMNAHPGD
SCHEMBL7076484 0.68 MMP2 (0.67) MMP2MMP9MMP14MMP1MMP3
SCHEMBL21148536 0.65 MMP2 (0.60) MMP2MMP9ADAM17PSMB5HDAC1
SCHEMBL2393157 0.65 LOXL2 (0.53) MEN1KMT2ARAB9AALDH1A1NPC1
SCHEMBL8036021 0.63 ESR1 (0.56) MEN1KMT2ARAB9AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003525203-A 2003-08-26 JP claimed
US-20030022893-A1 Hydroxamic and carboxylic acid derivatives BAXTER ANDREW DOUGLAS (GB) 2003-01-30 US claimed
US-6465468-B1 SUCH AS N-HYDROXY-2-(4-(4-CHLOROPHENYL)PIPERAZINE-1-SULFONYL)BENZAMIDE; INHIBITORS OF MATRIX METALLOPROTEINASE, ADAM OR ADAMTS ENZYMES; TREATMENT OF DEGENERATIVE DISEASES AND CERTAIN CANCERS DARWIN DISCOVERY LIMITED (GB) 2002-10-15 US claimed
EP-1163213-A1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES Darwin Discovery Limited (GB) 2001-12-19 EP claimed
WO-2000056704-A1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES DARWIN DISCOVERY LIMITED (GB) 2000-09-28 WO claimed
US-20030022893-A1 Hydroxamic and carboxylic acid derivatives BAXTER ANDREW DOUGLAS (GB) 2003-01-30 US disclosed
US-6465468-B1 SUCH AS N-HYDROXY-2-(4-(4-CHLOROPHENYL)PIPERAZINE-1-SULFONYL)BENZAMIDE; INHIBITORS OF MATRIX METALLOPROTEINASE, ADAM OR ADAMTS ENZYMES; TREATMENT OF DEGENERATIVE DISEASES AND CERTAIN CANCERS DARWIN DISCOVERY LIMITED (GB) 2002-10-15 US disclosed
EP-1163213-A1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES Darwin Discovery Limited (GB) 2001-12-19 EP disclosed
WO-2000056704-A1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES DARWIN DISCOVERY LIMITED (GB) 2000-09-28 WO disclosed